19270

Source:http://linkedlifedata.com/resource/pubmed/id/19270

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006233, umls-concept:C0087111, umls-concept:C0178539, umls-concept:C0441655, umls-concept:C0547047, umls-concept:C0597304, umls-concept:C1513095
pubmed:issue	1
pubmed:dateCreated	1977-10-20
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0373226
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Bromodeoxyuridine, http://linkedlifedata.com/resource/pubmed/chemical/Peptide Hydrolases, http://linkedlifedata.com/resource/pubmed/chemical/Thymidine
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	0014-4827
pubmed:author	pubmed-author:BosmannH BHB, pubmed-author:EvansII
pubmed:issnType	Print
pubmed:volume	108
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	151-5
pubmed:dateRevised	2004-11-17
pubmed:meshHeading	pubmed-meshheading:19270-Bromodeoxyuridine, pubmed-meshheading:19270-Cell Division, pubmed-meshheading:19270-Cell Line, pubmed-meshheading:19270-Dose-Response Relationship, Drug, pubmed-meshheading:19270-Hydrogen-Ion Concentration, pubmed-meshheading:19270-Peptide Hydrolases, pubmed-meshheading:19270-Thymidine
pubmed:year	1977
pubmed:articleTitle	Bromodeoxyuridine (BUdR) treatment of melanoma cells decreases cellular proteolytic activity.
pubmed:publicationType	Journal Article